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ABSTRACT 
Oxalate oxidase is a manganese containing enzyme that catalyzes the oxygen 
dependent oxidation of oxalate to carbon dioxide and hydrogen peroxide. Oxalate 
oxidase from Ceriporiopsis subvermispora (CsOxOx) is the first characterized 
bicupin oxalate oxidase. Potential applications of oxalate oxidase in cancer treatment, 
paper pulping, and biofuel cells highlight the need to study the effects of hydrogen 
peroxide on the CsOxOx catalyzed oxidation of oxalate. Membrane inlet mass 
spectrometry (MIMS) was used to directly measure initial rates of carbon dioxide 
formation and oxygen consumption in varying initial concentrations of hydrogen 
peroxide. This work demonstrates that hydrogen peroxide is both a reversible 
noncompetitive inhibitor of the CsOxOx catalyzed oxidation of oxalate and an 
irreversible inactivator. CsOxOx is irreversibly inactivated under turnover conditions 
and hydrogen peroxide plays a key role in this turnover dependent inactivation. The 
introduction of catalase to reaction mixtures protects the enzyme from inactivation 
allowing reactions to proceed to completion. Circular dichroism spectra suggest that 
hydrogen peroxide does not induce changes in CsOxOx global protein structure. 
Additionally, we show that the CsOxOx mediated mesoxalate reaction consumes 
oxygen and produces hydrogen peroxide, which is in contrast with previous proposals 
that the enzyme catalyzed the non-oxidative decarboxylation of this three carbon 
substrate. Finally, we observe a 13C kinetic isotope effect on the CsOxOx catalyzed 
reaction using MIMS which supports that the carbon-carbon bond cleavage of oxalate 
is at least partially rate limiting.  
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CHAPTER 1: INTRODUCTION 
Chapter 1.1: Oxalate Oxidase 
Oxalate oxidases (EC 1.2.3.4) are a group of enzymes that catalyze the oxidation of 
oxalate to carbon dioxide and hydrogen peroxide1-3(Figure 3). All oxalate oxidases 
(OxOx) characterized thus far belong to the cupin superfamily of proteins4-6. The 
cupin superfamily is a functionally diverse group of proteins that includes seed 
storage proteins, nuclear transcription factors, epimerases, dioxygenases, 
decarboxylases, oxidases, synthases, isomerases, and others5,7. Although functionally 
different, proteins belonging to the cupin superfamily share a common structural beta-
barrel motif5,8. The beta-barrel fold in the cupin domain of all known oxalate oxidases 
contains a manganese ion coordinated to three histidine residues and one glutamate 
residue9,10(Figures 1, 2 and 5). Most known oxalate oxidases are plant derived 
monocupins containing only a single cupin domain (Figure Error! Reference source 
not found.) with the exception of the bicupin enzyme derived from the white wood 
rot fungus Ceriporiopsis subvermispora. 
 
Figure 1: Ribbon structure of monocupin oxalate oxidase derived from barley (PDB 
code: 2et1) showing the beta-barrel fold typical of the cupin superfamily.  
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Figure 2: Ribbon homology structure of bicupin oxalate oxidase derived from 
Ceriporiopsis subvermispora. 
 
 
 
Figure 3: Reaction catalyzed by oxalate oxidase. 
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Figure 4: The proposed mechanisms of oxalate oxidase and oxalate decarboxylase. 
Modified from Moomaw et al6.  
 
The oxalate oxidase derived from Ceriporiopsis subvermispora (CsOxOx) is of 
particular interest to this study as it produces a unique bicupin form of oxalate oxidase 
containing two beta-barrel folds11,12. Interestingly, this enzyme has a high degree of 
amino acid sequence identity with another bicupin and manganese dependent oxalate 
degrading enzyme, oxalate decarboxylase from Bacillus subtilis1,8 from whose crystal 
structure the homology model of CsOxOx is derived12 (Figures 2 and 5). The oxalate 
decarboxylase from Bacillus subtilis (BsOxDC) catalyzes the non-oxidative, but 
oxygen dependent decarboxylation of oxalate to formate and carbon dioxide. Previous 
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work with both CsOxOx and BsOxDC have demonstrated that catalysis takes place in 
the N-terminal manganese binding site6,13, but as of yet there is no evidence for either 
enzyme that precludes catalysis from also taking place in the C-terminal domain14. 
Furthermore, other studies on BsOxDC suggest that the C-terminal Mn(II) site does 
catalyze decarboxylation15. No such evidence yet exists for CsOxOx. 
The current proposed catalytic mechanisms (Figure 4) for CsOxOx pools observations 
from studies on barley oxalate oxidase, CsOxOx, and BsOxDC and, therefore, shares 
similarities. EPR and metal analysis data and the observation that specific activity is 
correlated with manganese metal incorporation suggest the enzyme bound metal 
component to be Mn(II)10,11,16 in the resting state. Addition of oxalate was found to 
perturb the x-band EPR generated Mn(II) spectrum strengthening the hypothesis 
oxalate binds the enzyme bound Mn(II) ion directly during turnover16. Crystal 
structures confirm this as well as demonstrate that oxalate reversibly binds the 
manganese ion in a monodentate fashion17. It is assumed that the binding of oxalate 
perturbs the metal redox potential enough to facilitate the binding of diatomic oxygen 
and the oxidation of the Mn(II) center to Mn(III)18. Chemical precedent from the 
permanganate reaction with oxalate suggests that Mn(III) is the active species that 
facilitates the decarboxylation of oxalate ligand leaving the formyl bound free radical 
anion19. The existence of this intermediate is supported by EPR studies on CsOxOx 
and BsOxDC11,16. It is believed that the fate of the intermediate species is where the 
proposed mechanisms for the oxalate oxidases and oxalate decarboxylase diverge14,18. 
In the oxalate decarboxylase mechanism, the radical anion is protonated by a general 
acid and released from the manganese complex as formate11,20. In the oxalate oxidase 
mechanism, the formation of the radical anion intermediate is succeeded by the 
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formation of a, as of yet unobserved, percarbonate intermediate species prior to 
decomposition of the intermediate into carbon dioxide and hydrogen peroxide18.  
 
Figure 5: Homology models of the N-terminal (left) and C-terminal (right) 
manganese coordination centers of Ceriporiopsis subvermispora derived bicupin 
oxalate oxidase. Manganese ions (purple) and active site residues (carbon, cyan; 
nitrogen, blue; oxygen, red) are labelled. Swiss-Model (the Swiss Institute of 
Bioinformatics) was used to generate the homology model from the amino acid 
sequence of CsOxOx and the available structural data of BsOxDc (PDB ID 1UW8). 
The Pymol software (The PyMOL Molecular Graphics System, Schrödinger, LLC)6.  
 
Much of this mechanism is still disputed. A recent study by Whitaker et al. suggests 
an alternative mechanism in which only enzyme containing Mn(III) ions are active 
and react with oxalate directly without the need for oxygen binding21. Oxygen is then 
consumed by the carbon dioxide radical anion forming unbound superoxide which 
then regenerates the Mn(III) ion for further turnover producing hydrogen peroxide in 
the process21. 
 
Chapter 1.2: Oxalate oxidase as a component in biofuel cells 
Fuel cells convert the latent chemical energy from a fuel molecule, typically hydrogen 
or hydrocarbons, into electrical potential. The typical fuel cell has three main parts; a 
cathode, an anode, and an electrolyte connecting the two electrodes22. Fuel molecule 
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oxidation takes place at the anode of the fuel cell and is coupled with the reduction of 
an oxidant at the cathode. Redox chemistry taking place at both electrodes is made 
favorable by the addition of one or more electrocatalysts22. Most of the fuel cells in 
use today utilize metal catalysts; however, the use of biocatalysts in a subcategory of 
fuel cells called biofuel cells shows great promise23.  
Enzymes have a number of considerable advantages over conventional 
electrocatalysts22-24. For instance, enzyme active sites are specific for their substrate 
and are not easily inactivated by impurities found in fuels22. Also, modern fuel cells 
typically utilize costly precious metals as the catalysts for redox chemistry while 
biocatalysts can be inexpensively produced in mass using bioreactors. Additionally, 
advances in biofuel cell design combined with biocatalyst specificity obviate the need 
for the insulating membranes present in most liquid fuel cells significantly 
simplifying design22. However, one major barrier to practical application of 
biocatalysts in fuel cell design is the biocatalysts short life span; they are typically not 
as stable as their metal counterparts and tend to denature or degrade more rapidly. 
Therefore, techniques that extend the active lifespan of a biological redox catalyst are 
critical. Hickey et al. have published a study demonstrating the complete oxidation of 
glycerol to carbon dioxide and hydrogen peroxide using a combination of the organic 
catalyst 4-amino-2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) and the oxalate 
oxidase enzyme (from Hordeum vulgare)23 (Figure 6). 
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Figure 6: Image of the one-pot complete glycerol anodic oxidation half-cell23. 
 
Chapter 1.3: Oxalate oxidase as a potential cancer treatment 
Pancreatic ductal adenocarcinoma (PDA) is a deadly pancreatic cancer that undergoes 
metastasis early, presents late, and is resistant to chemo and radiotherapies25-28. These 
factors all contribute to the low 5-year survival rate after diagnosis of less than 6%29. 
Interestingly, the Kirsten rat sarcoma viral oncogene homolog (KRAS) is present in 
95% of PDA cases29 and is an attractive drug target. However, the KRAS protein 
itself has proven to be a difficult drug target26,30-32.  
A recent study found that KRAS positive pancreatic cancer cells have significantly 
higher concentrations of ascorbate derived oxalic acid compared to those 
concentrations in normal cells33. This prompted a study exploring the cytotoxic effects 
of CsOxOx on KRAS pancreatic cancer cells in the laboratory of Dr. Gaurab 
Chakraborti. Data (Figure 7) shows that cancer cells exposed to CsOxOx had 
significantly lower survivability compared to the buffer treated controls, and that the 
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CsOxOx treatment did not have a significant effect on the survivability of the normal 
cell line. These early results demonstrate the therapeutic potential for oxalate oxidase 
as a pancreatic cancer drug.  
 
 
Figure 7: Thirty hour MiaPaCa2 and HPDE (Human Pancreatic Duct Epithelial Cell 
Line) cell survival plots with and without CsOxOx. Points represent means. Error bars 
denote standard deviations. Those points marked with *** represent plots that are 
signficantly different from the control values (p value < 0.001).  
 
Chapter 1.4: Membrane inlet mass spectrometry 
Mass spectroscopy (MS) is a powerful analytical tool capable of both quantitative and 
qualitative analysis of a variety of compounds34. However, the inherent aqueous 
nature of biochemistry presents a barrier to the utility of this technique, and therefore 
MS is not often used for enzymatic assay and the determination of enzyme kinetic 
parameters. Mass spectrometry requires the maintenance of a strong vacuum within 
the analytical assembly in order to function properly and therefore only small gaseous 
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samples are compatible for analysis35. A number of sampling techniques have been 
developed that overcome this barrier34. The MS employed in this study uses a 
membrane (hence the name membrane inlet mass spectrometry or MIMS) through 
which gaseous and/or volatile samples are introduced into the high vacuum of the 
instrument via “pervaporation” (Figure 8). A sample undergoing pervaporation is 
adsorbed from the liquid matrix onto the surface of the sampling membrane, diffuses 
through the membrane, and then desorbs from the opposite side and into the high 
vacuum environment of the mass spectrometer36. 
 
 
Figure 8: The Hiden Analytical HPR40 Membrane Inlet Mass Spectrometer at 
Kennesaw State University. 
 
As the technique of mass spectrometry relies heavily on the principles of ion optics, 
sampled substances must be ionized prior to filtration and analysis. There are a 
number of techniques useful for sample ionization. Techniques include Matrix 
Assisted Laser Desorption Ionization (MALDI), Electrospray Ionization (ESI), and 
Electron Impact Ionization (EII). MALDI and ESI are modern techniques that provide 
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users with the ability to ionize and study large macromolecules (i.e. proteins). EII is 
an older and simpler technique suitable for gaseous or volatile small molecules. EII is 
the technique used in this study and will be the focus of further discussion. The EII 
technique ionizes the volatilized sample by direct bombardment with an electron 
beam perpendicular to sample flow36. The electron beam is generated by a heated 
filament providing a source of electrons that travel across the sample inlet stream and 
into an electron cage. Some portion of sample particles struck by electrons is ionized 
and is accelerated further into the instrument where they are then filtered according to 
their respective mass and charge.  
 
 
Figure 9: Diagram of the quadrupole mass filter. Modified from37. 
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Ion filtering is accomplished by measuring the time the ions take to travel a known 
distance (Time of Flight, TOF), or by deflection in a magnetic and/or electric field. A 
particularly powerful filtering tool is the quadrupole mass filter (Figure 9). The 
quadrupole mass filter is composed of two sets of two similarly charged poles; a pair 
of positive poles directly across from each other and a pair of negative poles directly 
opposite each other. The charges are maintained via a direct current supplied to each 
pole35. An alternating current is also supplied to each pair of poles. In this way, the 
positive poles act as a high mass filter while the two negative poles function as a low 
mass filter. The voltages of the currents as well as the frequency of the alternating 
currents can be altered to fine tune the filtering functions of the quadrupole 
attenuating the window of allowed masses to a width of 1 amu. Filtered ions are then 
detected using a faraday cup or single channel electron multiplier detector. In 
applications where ionized sample pressures are high, faraday cup detectors are more 
appropriate due to their durability and long life time. Single channel electron 
multiplier detectors are capable of detecting relatively small sample pressures, but are 
far more fragile and expensive34,35. The Hiden Analytical HPR-40 membrane inlet 
mass spectrometer is equipped with both a single channel electron multiplier detector 
and a faraday cup. 
Past studies of CsOxOx enzyme kinetics utilize a UV/Vis spectrophotometer assay 
coupling the production of hydrogen peroxide to the catalytic oxidation of 2, 2’-azin-
obis-(3-ethylbenzthiazoline-6-sulfonic acid) dye by horseradish peroxidase 
(HRP)10,11. The chemistry of the HRP presents an obvious barrier to inhibition studies 
using initial concentrations of hydrogen peroxide as the initial hydrogen peroxide 
concentration will also be used as substrate and therefore prevents an accurate rate 
determination by this assay. Therefore, MIMS was utilized to assay CsOxOx activity 
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by continuously measuring in real time the production of carbon dioxide and the 
consumption of oxygen by CsOxOx catalyzed reaction38. 
 
Chapter 1.5: Circular dichroism 
Circular dichroism (CD) is the difference between left-handed and right-handed 
polarized light absorbed from a chiral molecule. Absorbance of the two types of 
rotating radiation is also anisotropic; its degree is dependent on the orientation of the 
molecule to the incident radiation. Large biological molecules such as proteins 
contain many chiral molecules (amino acid residues) chained together and folded into 
some definite structure. Due to anisotropy, the CD of a large biological 
macromolecule is dependent on its three-dimensional structure and therefore CD 
measurements can be used to observe global structural changes.  
Circular dichroism spectroscopy involves scanning the CD values of a sample within 
a range of radiation wavelengths specific to the sample. Typically, protein sample CD 
spectra are obtained between the wavelengths of 170 nm to 250 nm or 250 nm to 320 
nm. The first group of wavelengths which includes the far UV are those at which the 
peptide backbone absorbs and can observe protein secondary structure such as beta-
sheet and alpha helices39-42. The later range corresponds to aromatic amino acids and 
CD measurements within it are able to discern tertiary protein structure changes39. 
There are a number of different ways to present the data from a CD experiment. The 
most basic CD value is simply the difference in absorbance between the left and right-
handed light (Equation Error! Reference source not found.)40,43. 
CD = Al − Ar (Eq. 1) 
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Here, CD is the CD value, Al is the absorbance of left-handed polarized light, and Ar is 
the absorbance of right-handed polarized light. However, this value can be rather 
vague. A more specific way to present CD data is molar CD which is derived directly 
from Beer-Lambert. Molar CD is calculated according to Equation Error! Reference 
source not found.40-42, 
[CD] =
CD
C×l
 
(Eq. 2) 
where CD is defined as in Equation Error! Reference source not found., C is the 
molar concentration of species of interest, and l is the pathlength in centimeters. For 
protein measurements, the species of interest are the individual peptide residues, and 
is the product of the molar concentration of a specific protein and the number of 
residues present per protein molecule. 
Classically, CD data can be presented as degree of ellipticity, which is the tangent of 
the smallest over the largest possible combinations of the magnitudes of the right-
handed and left-handed electrical field vectors (Equation 3)39,43. In equation 3, 
θ = tan
ER − EL
ER + EL
 
(Eq. 3) 
θ is the ellipticity in radians, ER is the magnitude of the electric field vector for the 
right-handed polarized light, and EL is the magnitude of the electric field vector for 
the left-handed polarized light. Assuming that the difference in absorption of left-
handed versus right-handed light is small and converting from radians to degrees it is 
possible to derive a constant of proportionality between molar ellipticity circular 
dichroism (Equation 4)39,43.  
θ = 32.982×CD (Eq. 4) 
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Here, θ is the ellipticity in degrees and CD is the circular dichroism as defined in 
Equation 1. It is also typical to report CD data in molar ellipticity which is the degrees 
of ellipticity divided by the product of the molar concentration of sample species and 
pathlength in meters. 
 
Chapter 1.6: Enzyme kinetics 
Enzyme kinetics aims to model mathematically an enzyme catalyzed reaction in order 
to gain mechanistic insight by comparing the behavior of the enzyme under study to 
the theoretical behavior of the model. The overall catalytic velocity of an enzyme 
under constant conditions is a function of the concentrations of all relevant enzymes, 
substrates, products, activators, and inhibitors. Equation 5, 
𝑣𝑖 = F([E], [S], [P], [A], [I]) (Eq. 5) 
represents a simplified mathematical description of the overall catalytic velocity 
where vi is equal to the change in the concentration of the species of interest (typically 
product) per unit time, [E] is the total concentration of enzyme, [S] is the total 
concentration of substrate, [P] is the total concentration of product, [A] is the 
concentration of activator, and [I] is the concentration of inhibitor. 
Typically, kinetic models are distinguished by first studying the relationship between 
substrate concentration and reaction velocity. Leonor Michaelis and Maud Menten 
were the first to mathematically describe a system in which a single substrate 
reversibly binds the enzyme and then is turned into product44-46. This simplest kinetic 
mechanism is shown in Figure 10.  
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Figure 10: Simple kinetic mechanism for a unireactant enzyme. 
 
In this model, the assumption is made that the binding and dissociation constants for 
the initial step are far faster than the chemical step in which the substrate is 
transformed to product. The conversion of [ES] to [P] is shown as irreversible and 
initial rate data implies that there is no significant concentration of product formed or 
reactant consumed during the period of assay. From these assumptions, they were the 
first to describe this type of system mathematically (Equation 6).  
𝑣0 =
𝑉𝑚𝑎𝑥× [S]
𝐾𝑀 + [S]
 
(Eq. 6) 
Here, vo is equal to the initial reaction rate, Vmax is equal to the maximal rate at which 
the enzyme is completely saturated with substrate, KM is equal to the substrate 
concentration which produces one-half the Vmax rate, and [S] is equal to the 
concentration of substrate. Later Briggs and Haldane suggested that there was no a 
priori reason that the substrate dissociation step should be very much faster than the 
enzymatic chemical processing step and therefore derived a more inclusive model 
assuming that there exists a steady state at which the concentrations of all 
intermediate species remains largely unchanged and that this steady state is achieved 
before any significant product formation has occurred45. Interestingly, both 
approaches yield the same characteristic rectangular hyperbola (Equation 6). The only 
difference between them is the meaning of the KM constant. In the Michaelis-Menten 
equation the KM is equal to the rate constant of substrate dissociation over the rate 
constant of substrate binding. While in the Briggs-Haldane model, the KM is equal to 
16 
 
the sum of the substrate dissociation constant and the rate of substrate conversion to 
product divided by the rate constant of substrate binding. The equation takes the same 
form but the definition of the constants change. In this way, most kinetic models 
describing enzyme catalysis are degenerate when looking at the effects of substrate 
concentration. Therefore, it is often necessary to perturb the systems using initial 
concentrations of inhibitors or activators to narrow down an appropriate kinetic 
model. 
Enzyme kinetic studies are typically illustrated graphically by plotting initial 
enzymatic reaction rate versus substrate concentration. If the resulting plot is a 
rectangular hyperbola, the data is consistent with Michaelis-Menten kinetics. The 
asymptote of the rectangular hyperbola is equal to the maximal velocity (Vmax) 
obtained under saturating concentrations of substrate. The substrate concentration that 
gives an initial reaction rate equal to one-half the asymptote represents the KM 
constant of the Michaelis-Menten equation44. Plotting the reciprocal of the initial 
reaction rate versus the reciprocal of the substrate concentration linearizes the classic 
Michaelis-Menten equation. This reciprocal plot is called the Lineweaver-Burk plot 
and provides visual insight into the kinetic mechanism. The y-intercept of the line is 
equal to the reciprocal of the maximum velocity, the x-intercept is equal to the 
negative reciprocal of the KM constant, and the slope of the line is equal to the ratio of 
the KM to Vmax values46,47. 
 
Chapter 1.7: Enzyme Inhibition Kinetics 
Enzyme inhibitors affect the kinetic parameters in ways dependent on the inhibition 
type. In a simple unireactant enzyme kinetic model, an inhibitor can alter the observed 
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kinetic parameters illustrating three broad types of inhibition. In the first type of 
inhibition, the inhibitor reversibly binds to the same enzyme species that binds the 
substrate, and therefore blocks the binding of substrate45. This increases the apparent 
KM value as additional substrate is needed to achieve the respective uninhibited 
velocity. The maximum reaction velocity (Vmax) is not affected at high substrate to 
inhibitor concentrations. The effect on the concentration of enzyme-substrate complex 
is insignificant. Uncompetitive inhibitors bind the enzyme-substrate complex only and 
prevent product formation. As less enzyme-substrate complex is able to form product, 
the maximal velocity is lowered in uncompetitive inhibition. Also, the removal of 
enzyme-substrate complex pushes the total pre-product equilibrium to the right 
reducing the apparent KM parameter. Noncompetitive inhibitors may reversibly bind a 
form of the enzyme that the experimentally varied substrate (S2 in Figure 11) does 
not, but there must be a reversible connection between the substrate binding species 
and the inhibitor binding species. (S1 in Figure 11): 
 
Figure 11: General kinetic scheme for a simple bireactant enzyme illustrating one 
possible mechanism of noncompetitive inhibition. 
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Figure 12: General scheme for noncompetitive inhibition for a simple unireactant 
enzyme. 
 
Alternatively, a noncompetitive inhibitor may bind to the enzyme form that the 
substrate binds and a different enzyme species (E and ES in Figure 12). In this 
“classic noncompetitive” case, the equilibrium constants for the binding of inhibitor 
with enzyme alone and inhibitor with another enzyme species are equal. When the 
two equilibrium constants are different, traditional inhibition nomenclature becomes 
ambiguous45,48 with this case being defined as a “mixed-type” inhibitor and not a 
noncompetitive inhibitor. However, there is no a priori reason that the equilibrium 
constants should be equal. For these reasons, it has been proposed that mixed 
inhibition be reclassified as noncompetitive inhibition, and in this study we refer to 
mixed inhibition simply as noncompetitive inhibition. Under this definition, a 
noncompetitive inhibitor will reduce the apparent maximal velocity, but can reduce, 
increase or have no effect on the KM parameter. 
Product inhibition describes a product molecule that is also an inhibitor of the enzyme 
that catalyzes its formation. The effects of product inhibition are observable from the 
overall velocity equation that accounts for the reverse reaction and the related 
product-enzyme complex species (Equation 7)45,46. In Equation 7, vi is the initial 
increase in concentration of product over time, [P]. [S] is the substrate concentration, 
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[P] is the product concentration, V1 is the maximal rate of product formation, V2 is the 
maximal rate of substrate formation, Ka is the equilibrium constant relating the rate 
constants of substrate binding and dissociation to and from the enzyme complex, and 
Kp is the equilibrium constant relating the rate constants of product dissociation and 
association to the enzyme complex. Each denominator term represents an 
intermediate enzyme species. The term representing the enzyme product complex(s) 
changes depending on the kinetic mechanism and allows one to differentiate between 
kinetic mechanisms that appear degenerate varying substrate concentration(s) alone.  
𝑣𝑖 =
𝑉1[S] − 𝑉2 (
𝐾𝑎
𝐾𝑝
) [P]
𝐾𝑎 + [A] + (
𝐾𝑎
𝐾𝑝
) [P]
 
(Eq. 7) 
Inhibitors can be further subdivided into complete and partial inhibitors. Complete 
inhibitors bind their target species and prevent progression towards product formation 
until the inhibitor has dissociated (rate constant kp in Figure 13). Partial inhibitors do 
not completely prevent progression through the main forward kinetic mechanism. 
Partial inhibitors only slow forward progress. Noncompetitive partial inhibitors bind 
to the free enzyme species and an enzyme complex species on the main scheme 
towards product release. The catalytically active inhibitor bound enzyme complex still 
produces product but at a slower rate. The reduction in the catalytic kinetic constant is 
captured by a factor, β (Figure 13). 
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Figure 13: Partial noncompetitive inhibition scheme. Modified from Segel48.  
 
All of the classical inhibitor types (noncompetitive, uncompetitive and competitive) 
reversibly bind their targets. Inhibitors exist that irreversibly bind their targets and 
therefore completely remove enzyme from the equilibrium. Removal of enzyme 
causes a decrease in Vmax but no change in KM, and is therefore indistinguishable from 
a noncompetitive inhibitor if one studies only the effects of inhibitor and substrate 
concentration on reaction velocity. To distinguish reversible noncompetitive 
inhibition from irreversible inhibition one needs to observe how maximal velocity 
changes in relation to assumed total enzyme concentration. A Vmax versus total 
enzyme concentration plot of an irreversibly inhibited enzyme will have a slope that is 
identical to that of the plot of the uninhibited enzyme. The x-intercept of the 
irreversibly inhibited enzyme plot will be shifted to the right of the uninhibited 
enzyme plot. The difference between the two x-intercepts is equal to the amount of 
enzyme that has been removed from the equilibrium. An enzyme concentration versus 
Vmax plot for a reversibly inhibited enzyme will have a lower slope than that of the 
uninhibited plot, and the two lines will intercept the x-intercept at the exact same 
value48. This plot is a powerful tool for visualizing both irreversible and reversible 
inhibition and allows one to comment on the degree of irreversible inactivation. 
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Chapter 1.8: The motivation and novelty of this work 
This study seeks to better understand the role of CsOxOx as a biocatalyst in biofuel 
cell, cancer, and other applications while leveraging observations to gain mechanistic 
insights. Data suggesting a potential role for CsOxOx as a cancer therapeutic beget 
questions regarding the effects of hydrogen peroxide build up during enzymatic 
turnover. There is very little literature characterizing the effects of hydrogen peroxide 
on oxalate degrading enzymes. Initial rate inhibition studies on oxalate decarboxylase 
suggest that hydrogen peroxide is not an inhibitor of the enzyme13. Observations by 
EPR found that the addition of hydrogen peroxide to barley oxalate oxidase did not 
perturb the manganese center16. The only study looking at the inhibitory effects of 
hydrogen peroxide on oxalate oxidase examined a broad spectrum of compounds 
found in paper bleaching filtrates49. This study reported that barley oxalate oxidase 
activity is not significantly reduced up to concentration of 1 mM hydrogen peroxide, 
but only 30% of the activity remains at 20 mM hydrogen peroxide. As hydrogen 
peroxide is a product of the CsOxOx catalyzed reaction any application utilizing 
CsOxOx as a biocatalyst will benefit from a more complete understanding of the 
effects of hydrogen peroxide on the enzyme. Additionally, the mechanism employed 
by CsOxOx in the oxidation of oxalate has been well studied, but questions still 
remain regarding the existence and fate of the percarbonate radical and how the 
resulting products influence enzyme activity. Enzyme product inhibition studies are 
commonly used to gain insight into enzyme mechanisms and, among other things, to 
identify abortive enzyme product complexes. Therefore, efforts to characterize 
hydrogen peroxide product inhibition of CsOxOx will lead to further mechanistic 
insight. 
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Efforts were also made to further characterize CsOxOx enzyme promiscuity.  Enzyme 
promiscuity (for the purposes of this study is defined as substrate ambiguity) is a 
common phenomenon and useful in a large number of applications. The application of 
isothermal titration calorimetry (ITC) has demonstrated the ability of CsOxOx to 
utilize a number of small di-carboxylic acid molecules as substrates50. Additionally, 
the three-carbon molecule, mesoxalate (oxopropanedioic acid), has been shown to be 
a substrate for the CsOxOx-catalyzed reaction, with a kinetic parameters comparable 
to that of oxalate. The usefulness of OxOx as a biocatalyst in biofuel cells23 may 
inform efforts to modify the properties of CsOxOx through rational design/directed 
evolution. Characterizing the extent of promiscuity of CsOxOx is important as it may 
provide a basis for these modifications. Furthermore, elucidation of the reaction 
products of the CsOxOx catalyzed reaction with mesoxalate is important to inform the 
type of reaction that is catalyzed (oxidative or nonoxidative) and could lead to further 
mechanistic insight. 
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CHAPTER 2: EXPERIMENTAL 
Chapter 2.1: Materials 
13C3-glycerol and 
13C2-oxalate were obtained from Cambridge Isotope Laboratories. 
Lyophilized catalase powder from bovine liver was a purchased from Sigma Aldrich. 
All other reagents described were purchased from Sigma Aldrich or Fisher Scientific 
and were of the highest purity available unless otherwise stated.  
 
Chapter 2.2: Expression/purification of CsOxOx 
CsOxOx was recombinantly expressed in Pichia pastoris as previously described11.  
The CsOxOx sequence (GenBank accession number: AJ746412) was amplified using 
engineered primers incorporating an XbaI restriction site and Kex2 protease cleavage 
site at the 5’ end. At the 3’end an XhoI site was added. After digestion with XhoI and 
XbaI, the resulting fragments were ligated into pPICZαA vector (Invitrogen) also 
previously digested with XhoI and XbaI. The Invitrogen EasyComp transformation 
kit was then used to introduce the recombinant plasmid into Pichia pastoris X-33. The 
resulting recombinant cells, capable of growth on plates containing methanol as the 
sole carbon source and capable of growth in the presence of Zeocin, were inoculated 
into 5 baffled flasks containing 500 mL of MGY media (1.34% yeast nitrogen base, 
1% glycerol, 4 ×10−5 % biotin, 5 mM MnCl2) and incubated overnight at ~29°C under 
constant agitation. The yeast cells were then harvested by centrifugation at 8000 RPM 
for 8 minutes. The supernatant was poured off and the pellets were each resuspended 
in 500 mL of MM media (1.34% yeast nitrogen base, 4 ×10−5 % biotin, 0.5% 
methanol, 5 mM MnCl2). The suspensions were then incubated at ~29°C under 
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constant agitation for 5 days. At the beginning of each day of incubation an additional 
aliquot of methanol (0.5%) was added. After the fifth day, the cells were removed by 
centrifugation at 10,000 RPM and the supernatant was concentrated to a volume of 
roughly 50 mL using both the Pellicon XL and Amicon ultra filtration devices. The 
concentrate was then dialyzed exhaustively against 25 mM imidizole chloride buffer 
(pH 7.0). Dialyzed concentrate was then further purified using a DEAE-Sepharose 
Fast Flow column. The concentration of sodium chloride in the mobile phase buffer A 
(50 mM imidazole-Cl, pH 7.0) was slowly increased using a gradient pump, and 
eluent was collected in 10 mL fractions. Fractions containing oxalate oxidase activity 
were then pooled and ammonium sulphate was then added to the pooled fractions to 
concentration of 1.7 M. This solution was then applied to a Butyl-Sepharose column 
and protein was eluted using a linear gradient from 100% buffer B (50 mM 
Imidazole-Cl, 1.7M ammonium sulfate) to 100% buffer A. Fractions were again 
tested and those containing oxalate oxidase activity were pooled and concentrated to a 
target specific activity. This method has been previously described and multiple 
times6,11,38,51. 
 
Chapter 2.3: Chromatographic separation of small carboxylic acid molecules 
by HPLC 
HPLC separation of small carboxylic acid molecules was achieved on a 300 mm x 7.8 
mm Aminex HPX-87H column, using sulfuric acid solution as the mobile phase (4 
mM, 0.6 mL/min)23,52. Samples were injected (one 25 µL sample injection every 
thirty minutes) into the HPLC system. The absorbance of the eluent at a wavelength 
of 230 nm was recorded over time and the data was analyzed using the Dionex 
PeakNet software. 
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Chapter 2.4: Observation of global structural protein changes by circular 
dichroism  
Structural changes of the wild type CsOxOx enzyme brought on by increasing 
hydrogen peroxide concentrations were measured using circular dichroism 
spectroscopy. The JASCO J-1500 Spectropolarimeter (JASCO Inc.) was used to 
measure the molar ellipticity of the samples. A sample of purified CsOxOx enzyme 
was exchanged into 25 mM potassium phosphate (pH 7.0), and diluted with 25 mM 
potassium phosphate buffer until its CD spectrum reached a minimum at 207 nm. 
Aliquots of concentrated hydrogen peroxide were then added to the protein sample 
resulting in final concentrations of 0, 4, 8, 12, 16, and 20 mM hydrogen peroxide. A 
Teflon stopper was used to retard evaporation. The scan rate, time constant and 
numbers of scans were 10 nm/min, 2 s, and 3, respectively. Wavelengths were 
recorded over the range of 195-250 nm. The scan rate and bandwidth were 10 nm/min 
and 1 nm, respectively, and each spectrum was an accumulation of five scans. A 
blank spectrum was performed with buffer and subtracted from the spectra. 
 
Chapter 2.5: UV-Vis horseradish peroxidase coupled CsOxOx kinetic assay 
Samples were assayed on a UV-Vis assay that utilizes horseradish peroxidase to 
couple the formation of oxalate derived hydrogen peroxide to the oxidation of 2,2’-
azinobis- (3-ethylbenzthiazoline- 6-sulfonic acid) (ABTS) dye10. The spectrometer is 
first blanked with reaction solution (50 mM potassium oxalate, 5 mM ABTS, 25 U 
horseradish peroxidase and 50 mM sodium succinate, pH 4.0) and then the sample is 
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added prior to measuring the increase in absorption at 650 nm over 20 seconds. A 
molar extinction coefficient of 10,000 M-1cm-1 for the ABTS dye was assumed. 
 
Chapter 2.6: MIMS setup 
The inlet probe comprised a length of tubular silastic membrane (1.96 mm OD and 
1.47 mm ID) sealed at one end by a ruby/sapphire ball (2 mm) and attached at the 
other end to a piece of glass tubing (120mm length, 2.3 mm ID, and 6.35 mm OD). A 
stainless steel membrane support spring (316SS) was used to support the tubular 
silastic membrane at running vacuum pressures. The length of silastic membrane from 
the ruby/sapphire ball to the beginning of the glass tubing was 3.3 mm. The glass 
tubing is connected quartz tubing was attached to an elbow joint that exited directly 
into the main vacuum chamber of a Hiden Analytical HPR-40 DSA Membrane Inlet 
Mass Spectrometer. 
 
Figure 14: Close-up of the probe mass spectrometer fittings. 
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Chapter 2.7: MIMS oxalate oxidase assay 
To determine the rate of catalysis by CsOxOx, a solution of sodium succinate buffer 
(50 mM, pH 4.0) and potassium oxalate (50 mM, pH 4.0) was incubated at room 
temperature for 5 minutes with the MIMS probe submerged and data collected at 32 
m/z and m/z 45 or 44. After a stable baseline reading was achieved, a sample of 
CsOxOx of known concentration was added to the buffered substrate solution. The 
ion currents were then recorded for another 20 minutes. 
The rate of MIMS signal change after enzyme addition was determined by plotting 
the first minute of linear increase in the m/z 45 signal versus time in minutes and the 
slope of the linear best fit line as determined using Microsoft Office Excel 2010. The 
baseline slope was subtracted from the sample rate and the difference was then 
divided by the conversion factor from the standard curve and the mass of CsOxOx 
enzyme (in mg) utilized in the reaction to obtain a specific activity in millimoles CO2 
per minute per milligram of CsOxOx.  
 
Chapter 2.8: Determination of KM and Vmax 
The KM values for the CsOxOx catalyzed oxidation of oxalate was determined by 
plotting the initial rates at various oxalate substrate concentrations (0.1 to 10 KM) 
using the MIMS assay previously described in Section 2.6. Specific activities were 
plotted versus millimolar oxalate substrate concentration and the plot was fit to the 
typical Michaelis-Menten rectangular parabola using the KaliedaGraph 4.1 software, 
and the KM was determined from the fit parameters. For product inhibition studies, the 
KM and Vmax was determined by measuring the specific activities of MIMS assay 
solutions containing oxalate concentrations of 20, 10, 5, 2.5, 1, 0.5, 0.25, 0.1, and 0.05 
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mM. Again, the specific activities were plotted versus millimolar oxalate 
concentrations and the plot was fit to the typical Michaelis-Menten rectangular 
parabola using the KaliedaGraph 4.1 software, and the kinetic constants were 
calculated directly from the fit parameters. Additional KM and Vmax determinations 
were obtained for the oxalate reaction at varying initial hydrogen peroxide 
concentrations (2 mM, 4 mM, 6 mM, 10 mM, 14 mM, and 20 mM). All Lineweaver-
Burk plots were obtained by plotting the reciprocal specific activities versus the 
respective reciprocal substrate concentration using the KaliedaGraph 4.1 software. 
 
Chapter 2.9: Determining reversibility of inhibition 
The Vmax in µmol/minute was determined as previously described for solution 
containing 0 and 10 mM hydrogen peroxide, and total enzyme concentrations of 
104.5, 69.7, 34.8, and 17.4 nM. Vmax determinations at both initial concentrations of 
hydrogen peroxide were plotted against total enzyme concentrations, and the two 
plots were fit to linear functions using the KaliedaGraph 4.1 software46. 
 
Chapter 2.10: Characterizing turnover dependent inactivation  
In order to explore further the inactivation of CsOxOx during turnover, 772 nM 
enzyme was incubated at room temperature with 10 mM potassium oxalate in 50 mM 
sodium succinate, pH 4.0 in the presence and absence of 1.0 mg/mL bovine catalase. 
To test the stability of the enzyme, control incubations without oxalate present and 
with and without 10 mM hydrogen peroxide were also maintained at room 
temperature. Aliquots were removed at time 0, 2 hours, and 24 hours and assayed to 
determine initial rates under saturating substrate conditions (>10 KM) as described in 
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Chapter 2.7: MIMS oxalate oxidase assay, above. Total enzyme concentrations of 
128.8, 103.0, 77.2, and 51.5 nM were measured in duplicate. Rates under these 
conditions were plotted against total enzyme concentration for the 0 and 2-hour time 
points, as previously described53.  
 
Chapter 2.11: Determining the KI and α kinetic constants for the 
characterization of complete inhibition 
Our data is suggestive of an ordered catalytic mechanism and the use of the terms KI 
and KI is most appropriate. Alternative terms (Kii and Kis) are sometimes seen in the 
literature when less information is known about the order of binding45,48. In an effort 
to identify better define the kinetic constants, KI and α (Figure 13), as well as to 
discern complete versus partial noncompetitive inhibition, CsOxOx was assayed in 
10, 2.5, 1.43, and 1 mM concentrations of oxalate in 40, 20, 10, and 0 mM initial 
concentrations of hydrogen peroxide. KI and α where estimated from the slope and 
intercept secondary plots of the reciprocal plots versus hydrogen peroxide 
concentration46. A separate calculation of the  value was also determined by finding 
the reciprocal velocity value at which the reciprocal plots intersect.  
1
𝑣
=
1
𝑉𝑚𝑎𝑥
(
𝛼 − 1
𝛼
) 
(Eq. 8) 
Here, v is the initial velocity at the intersection of the plots, Vmax is the velocity at 
saturating oxalate concentrations, and α is the factor that captures the relationship 
between the equilibrium constants of the two inhibitor binding steps. In order to find a 
value and uncertainty for the intersection point the average of unique intersection 
points calculated as the intersection of each line with every other line was determined. 
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Chapter 2.12: Effects of anaerobic incubation of CsOxOx with oxalate 
Previous literature from Whittaker et al. demonstrates complete inactivation of barley 
oxalate oxidase by incubation of the enzyme with substrate in the absence of oxygen 
supporting Mn(III) containing enzyme as the active form that directly acts on 
oxalate21. A similar experiment was performed to determine if the same is true in 
CsOxOx. A solution containing sodium oxalate (10 mM, pH 4.0) and sodium 
succinate (50 mM, pH 4.0) was purged with nitrogen for one hour. After one hour, 
CsOxOx was added to the, still purging, solution (77 nM). The solution was then 
allowed to incubate under nitrogen for another 40 minutes before being opened to the 
air.  The whole process was observed in real time using membrane inlet mass 
spectrometry measuring particles with mass-to-charge ratios of 45 and 32. 
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CHAPTER 3: RESULTS AND DISCUSSION 
Chapter 3.1: Kinetic plots for hydrogen peroxide are consistent with 
noncompetitive inhibition 
The Michaelis-Menten and Lineweaver-Burk plots for varying concentrations of 
hydrogen peroxide are shown in Figure 15 and 16, respectively. The observed Vmax is 
represented as a percentage of the uninhibited Vmax and the KM values determined 
from the nonlinear regression of the Michaelis-Menten plots for the CsOxOx 
catalyzed oxidation of oxalate at varying initial concentrations of hydrogen peroxide 
obtained using the MIMS assay is presented in Table 1. With an initial hydrogen 
peroxide concentration of zero, the Vmax was estimated to be 2.03 ± 0.03 U/mg and 
the KM was estimated at 0.47 mM. Similarly, 2 mM initial hydrogen peroxide 
concentration the Vmax is 1.65 ± 0.03 U/mg and the KM is 0.47 mM, at 4 mM initial 
hydrogen peroxide concentration Vmax is 1.35 ± 0.02 U/mg and the KM is 0.56 mM, 
and at 10 mM initial hydrogen peroxide concentration the Vmax is 0.87 ± 0.02 U/mg 
and the KM  is 0.76 mM. Initial concentrations of hydrogen peroxide reduce the 
apparent Vmax and appear to increase the observed KM value. Further investigation into 
the effects of hydrogen peroxide on the apparent KM is described in Chapter 3.4. 
These data suggest that hydrogen peroxide behaves as a mixed-type or 
noncompetitive inhibitor of CsOxOx. All models consistent with this observation 
have hydrogen peroxide reversibly binding both CsOxOx alone and another CsOxOx 
complex. 
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Figure 15: Michaelis-Menten plots of CsOxOx activity on oxalate at 0 mM (black, 
closed diamonds), 2 mM (red, closed triangles), 4 mM (blue, closed circles), and 10 
mM (green, closed squares) initial concentrations of hydrogen peroxide. Coefficients 
of determination for the non-linear fits are as follows: 0.994 for the 0 mM hydrogen 
peroxide plot, 0.990 for the 2 mM hydrogen peroxide plot, 0.994 for the 4 mM 
hydrogen peroxide, and 0.990 for the 10 mM hydrogen peroxide plot. 
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Figure 16: Lineweaver-Burk plots of CsOxOx activity on oxalate at 0 mM (black), 2 
mM (red), 4 mM (blue), and 10 mM (green) initial concentrations of hydrogen 
peroxide. Coefficients of determination for the linear fits are as follows: 0.997 for the 
0 mM hydrogen peroxide plot, 0.995 for the 2 mM hydrogen peroxide plot, 0.993 for 
the 4 mM hydrogen peroxide, and 0.996 for the 10 mM hydrogen peroxide plot. 
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Table 1: Percent of the uninhibited specific activity and KM values for the CsOxOx 
catalyzed oxidation of oxalate in the presence and absence of hydrogen peroxide 
measured by MIMS. 
  
 
Chapter 3.2: [E] vs Vmax plots are consistent with hydrogen peroxide as a 
reversible inhibitor 
Figure 17 shows the plots of total enzyme concentration, [E], versus oxalate saturated 
enzyme reaction velocity (Vmax) for CsOxOx incubated with a 10 mM initial 
concentration of hydrogen peroxide and with no initial concentration of hydrogen 
peroxide. The best fit linear equation to the plot of Vmax versus total enzyme 
concentration for those experiments with no initial hydrogen peroxide concentration 
had a slope of 0.00050 U/nM ± 0.00004 U/nM, a y-intercept of -0.002 U ± 0.003, and 
the coefficient of determination was 0.95. The best fit linear equation to the plot of 
Vmax versus total enzyme concentration for those experiments with an initial hydrogen 
peroxide concentration of 10 mM had a slope of 0.00023 U/nM ± 0.00002 U/nM, a y-
intercept of -0.001 U ± 0.001 U, and the coefficient of determination was 0.94. The 
slope of the line fit to the data without hydrogen peroxide was significantly greater 
that the slope of the line fit to the data obtained with an initial concentration of 
hydrogen peroxide suggesting that hydrogen peroxide is affecting the number and 
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distribution of intermediate substrate species at steady state. The x-intercept for the 
uninhibited plot was 7 nM ± 8 nM and the x-intercept for the inhibited plot was 8 nM 
± 9 nM. The x-intercepts from both linear fits are not significantly different and 
appear to intersect the x-axis at approximately the same point suggesting that enzyme 
is not inactivated upon addition of hydrogen peroxide within the time and chemical 
restraints of the kinetic assay. From this plot, it seems all or most of the inhibition of 
CsOxOx by hydrogen peroxide under the constraints of the kinetic assay is reversible, 
and this is consistent with hydrogen peroxide as a reversible noncompetitive inhibitor. 
The lines do intersect at a non-zero point to the right of the principal axis. An 
explanation of this is likely that the assumed protein concentration determined using 
the Lowry protein determination slightly overestimated the protein concentration. The 
shift in the x-intercept from 0 only represents an overestimation of 4 nM ± 4 nM, or 
0.6% of the total concentration of protein. Notably, one standard deviation from the x-
intercept for both best fit lines includes zero. 
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Figure 17: The Vmax versus total CsOxOx enzyme concentrations at initial hydrogen 
peroxide concentrations of 0 mM (black) and 10 mM (blue). Each point represents an 
entire Vmax determination using oxalate concentrations of 0.2, 0.5, 1.0, 5.0, and 10.0 
mM. Coefficients of determination for the linear fits are as follows: 0.97 for the 0 mM 
hydrogen peroxide plot, and 0.97 for the 10 mM hydrogen peroxide plot. 
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Chapter 3.3: CD spectra of CsOxOx show no change in global structure in 
hydrogen peroxide 
Circular dichroism spectroscopy was implemented to assess the effects of hydrogen 
peroxide on the global protein structure of CsOxOx. Image A in Figure 18 shows 
overlaid CD spectra of CsOxOx at varied hydrogen peroxide concentrations (no H2O2, 
light blue; 4 mM H2O2, orange; 8 mM H2O2, grey; 12 mM H2O2, yellow; 16 mM 
H2O2, dark blue; 20 mM H2O2, green). In all hydrogen peroxide concentrations, the 
CsOxOx spectrum maintains most of its characteristic shape. The average global 
minimum was 208.6 nm ± 0.4 nm. A Pearson coefficient of 0.714 was found between 
hydrogen peroxide concentrations and the associated wavelength at the global 
spectrum minima suggesting that as hydrogen peroxide concentration increases the 
wavelength at the minima shifts to the right. The average value of the minima was -
7592.6 deg·cm2·dmol-1 ± 182.7 deg·cm2·dmol-1. A Pearson coefficient of 0.995 was 
found between the hydrogen peroxide concentration and the magnitude of the global 
minima suggesting that as hydrogen peroxide concentration increases the minima 
increases in value (decreases in magnitude). Images B and C in Figure 18 demonstrate 
the effects of thermal denaturation and protein concentration on the observed CD 
spectrum, respectively. These data, reported previously by our lab have been included 
for comparison with those data obtained using hydrogen peroxide51. All spectra 
display a similar shape with a single minimum. As temperature increases the value of 
the minima decreases significantly (Pearson coefficient -0.967) and the wavelength at 
the minima shifts to the right (Pearson coefficient 0.873). The minima value increases 
significantly with increasing enzyme concentration (Pearson coefficient 0.892) as 
does the wavelength at the minima (Pearson coefficient 0.967). Both temperature and 
CsOxOx concentration appear to have far greater effects on the minima value than 
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hydrogen peroxide concentration. Hydrogen peroxide by contrast does not appear to 
significantly shift the minimum wavelength value. Therefore, we conclude that 
hydrogen peroxide concentrations up to 20 mM have little effect on the overall 
secondary structure of the CsOxOx protein. 
 
 
Figure 18: CD spectra of CsOxOx with (A) increasing concentration of hydrogen 
peroxide (light blue, no H2O2; orange, 4 mM H2O2; grey, 8 mM H2O2; yellow, 12 mM 
H2O2; dark blue, 16 mM H2O2; green, 20 mM H2O2), (B) at varying temperatures 
(0.68 mg/ml CsOxOx in 25 mM potassium phosphate (pH 7.0) at different 
temperatures: grey, 90 °C; burgundy, 80 °C; dark blue, 70 °C; green, 60 °C; blue, 50 
°C; yellow, 40 °C; light grey, 30 °C; orange, 20 °C; light blue, 10 °C), and (C) at 
varying protein concentrations: light blue, 0.33 mg/ml; orange, 0.5 mg/ml; grey, 0.7 
mg/ml; yellow 1.0 mg/ml; dark blue, 1.5 mg/ml; green, 3.0 mg/ml).  
 
Chapter 3.4: Characterization of complete noncompetitive inhibition 
In an effort to better characterize the noncompetitive inhibition observed in Figures 19 
and 20, experiments at substrate concentrations resulting in Lineweaver-Burk plots of 
equidistance and equal weight were carried in a larger range of hydrogen peroxide 
concentrations. Plots of reciprocal initial oxalate oxidase activity versus reciprocal 
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oxalate concentration for CsOxOx are shown in Figure 19. Secondary plots of the 
slopes and intercepts of the reciprocal plot linear best fit lines versus hydrogen 
peroxide concentration are shown Figure 20. The αKI and KI values are estimated to 
be 7.91 ± 1.12 and 2.84 ± 1.06 from the x-intercepts of the reciprocal plot intercept 
and slope versus hydrogen peroxide concentration secondary plots. The slope and 
intercept secondary plots are linear (R2 values greater than 0.99) suggesting that the 
hydrogen peroxide inhibition of CsOxOx is complete and not partial (up to 40 mM 
hydrogen peroxide).  From these data, α was estimated to be 2.79 ± 1.12. A way to 
mathematically check this value is to use the regression lines from the reciprocal 
plots48. These constellate around the point (-0.207±0.011, 0.195±0.042). This 
corresponds to an α value of 2.25 ± 0.59. The values for the α constant determined 
using two different methods agree well with one another and demonstrate that 
hydrogen peroxide is a noncompetitive inhibitor. It is assumed here that hydrogen 
peroxide inhibition of oxalate oxidase takes a form similar to the scheme shown in 
Figure 12. 
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Figure 19: Plots of reciprocal initial oxalate oxidase activity versus reciprocal oxalate 
concentration for CsOxOx in 0 (circle), 10 (square), 20 (diamond), and 40 (triangle) 
mM hydrogen peroxide. Coefficients of determination for the linear fits are as 
follows: 0.969 for the 0 mM hydrogen peroxide plot, 0.992 for the 10 mM hydrogen 
peroxide plot, 0.984 for the 20 mM hydrogen peroxide plot, and 0.864 for the 40 mM 
hydrogen peroxide plot.  
 
 Figure 20: Secondary plots of the slopes and intercepts from of the reciprocal plot 
linear best fit lines (Figure 19) versus hydrogen peroxide concentration. Coefficients 
of determination for the linear fits are as follows: 0.998 for the slope secondary plot, 
and 0.998 for the intercept secondary plot. 
 
Slope secondary plot 
Intercept secondary plot 
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Oxygen is assumed to be at saturating concentrations and therefore the binding of 
oxygen and subsequent decarboxylation can be simplified into one single irreversible 
step38. Under these conditions the CsOxOx enzyme is effectively a unireactant system 
and can be modelled as such. Literature suggests that oxygen binds CsOxOx after the 
binding of oxalate. If this is true, the simplest model for hydrogen peroxide inhibition 
is that of a noncompetitive inhibitor that binds both the enzyme alone and the enzyme 
substrate complex. Linear secondary plots suggest that inhibition is complete and 
inhibitor bound enzyme species are not directly capable of catalysis. With this model, 
one can then assign meaning to the determined αKI and KI values. Under these 
assumptions, the KI is the equilibrium constant describing the dissociation of the 
enzyme-inhibitor complex, and the αKI is the equilibrium constant describing the 
dissociation of inhibitor from the enzyme-substrate-inhibitor complex. The KI value is 
significantly smaller than the αKI value suggesting that hydrogen peroxide binds the 
CsOxOx enzyme alone stronger than it associates with the CsOxOx-oxalate complex, 
and is consistent with hydrogen peroxide as a product inhibitor that is formed from 
catalysis, remains bound to the CsOxOx enzyme, and then dissociates into bulk 
solution. The αKI value suggests that while oxalate binding weakens the association of 
the hydrogen peroxide inhibitor it does not prevent its binding suggesting that 
hydrogen peroxide binds CsOxOx at a site other than the oxalate binding site. That 
oxygen has a binding site other than the active site manganese ion has been suggested 
for OxDC54. Experiments describing the effects of varying concentrations of oxygen 
on hydrogen peroxide product inhibition would allow further comment regarding the 
binding of oxygen with respect to hydrogen peroxide. 
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Chapter 3.5: HPLC and MIMS analysis show that CsOxOx is inactivated 
during turnover 
Figure 21 shows the degree of oxalate oxidation by CsOxOx over time with (Figure 
21B) and without (Figure 21A) catalase. Succinate, oxalate, and hydrogen peroxide 
standards eluted at 12.4, 6.9, and 6.3 minutes and informed the assignment of peaks in 
Figure 21. In Figure 21A, the peak at 6.7 minutes decreases in area over time starting 
at 60.85 mAU/minutes then slowly decreasing to 50.76 mAU/minutes after 24 hours 
of reaction. Roughly 83% of the oxalate (initially 10 mM) remained after 24 hours. 
The succinate peak eluting at 12.2 minutes remains largely the same for all time 
points consistent with its role as a buffer (22.85 mAU/minutes at 0 minutes, 24.33 
mAU/minutes at 20 minutes, 23.51 mAU/minutes at 1 hour, 21.88 mAU/minutes at 2 
hours, and 22.61 mAU/minutes at 24 hours). The peak representing hydrogen 
peroxide, eluting at 6.4 minutes, is apparent at time points 20 minutes, 1 hour, 2 
hours, and 24 hours. The area of this peak increases over time starting at 3.37 
mAU/minutes at 20 minutes and increases to 13.71 mAU/minutes after 24 hours 
consistent with the progression of the oxidative decarboxylation of oxalate. The 
hydrogen peroxide and oxalate peaks had some degree of overlap and confounded 
precise estimation of peak area and, by extension, chemical concentrations. 
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Figure 21: HPLC stacked chromatograms of the products of the CsOxOx catalyzed 
oxalate reaction. An aliquot of the incubation reaction without (A) or with (B) 
recombinant bovine catalase was analyzed at 0 minutes, 20 minutes, 1 hour, 2 hours, 
and 24 hours.  
 
Stacked HPLC chromatograms in Figure 21B demonstrate oxalate oxidation by 
CsOxOx over 24 hours in the presence of catalase. As in the data shown in Figure 
21A, the succinate peak eluting at 12.2 minutes remained roughly the same over the 
time tested (22.53 mAU/minutes at 0 minutes, 24.20 mAU/minutes at 20 minutes, 
24.01 mAU/minutes at 1 hour, 24.31 mAU/minutes at 2 hours, and 24.31 
mAU/minutes at 24 hours). The oxalate peak area began at 57.08 mAU/minutes at 0 
minutes then decreased to 1.63 mAU/minutes after 24 hours. Roughly 3% of the 
oxalate substrate remains after 24 hours suggesting that the oxidation of the oxalate 
substrate (initially 10 mM) is nearly complete. Additionally, hydrogen peroxide 
generated during turnover does not build up in concentrations observed in the reaction 
without catalase. There is no apparent build-up of hydrogen peroxide over the 24 
hours consistent with the presence of active catalase. 
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In analogous experiments employing the MIMS, samples of CsOxOx after 24 hours 
of turnover without catalase were assayed according to the method described in 
Chapter 2.7. CsOxOx was observed to be relatively stable under the conditions of the 
assay in the absence of substrate, retaining 73% of the original enzyme activity after 
24 hours at room temperature diluted in buffer. CsOxOx incubated for 2 hours in 10 
mM oxalate had only 20 percent of its original activity (not shown), and no activity 
was detected in enzyme incubated for 24 hours in 10 mM oxalate (Table 2). CsOxOx 
incubated for 24 hours in the presence of 10 mM oxalate and bovine catalase retained 
approximately 80% of its original activity; preventing the build-up of hydrogen 
peroxide prevented the previously observed inactivation. The inactivation of CsOxOx 
is only observed after pre-incubation with oxalate. Pre-incubation in buffer or buffer 
and hydrogen peroxide show no inactivation. Furthermore, addition of catalase to the 
turnover inactivated enzyme does not recover any significant amount of activity.  
Table 2: MIMS measurements of CsOxOx with no prior turnover with and without 
hydrogen peroxide, and turnover in the absence and in the presence of 1.0 mg/mL 
bovine catalase. Uncertainties are presented as standard deviations from the mean 
value. Samples that had undetectable activity are signified by “nd”.  
 
 
In order to further investigate the CsOxOx turnover dependent inactivation, a plot of 
reaction velocities versus total enzyme concentration was prepared for enzyme treated 
with two hours of turnover prior to assay and enzyme incubated under similar 
conditions for 2 hours but without turnover (Figure 22). The slope of the line 
generated from turnover treated enzyme data is shallower than the line generated from 
Time, hours
No prior turnover, 
U
No prior turnover in 
10 mM hydrogen 
peroxide, U
Turnover 
treated, U
Turnover 
treated plus 
catalase, U
0 0.026 ± 0.001 0.023 ± 0.001 0.026 ± 0.001 0.030 ± 0.001
24 0.019 ± 0.001 0.01 ± 0.001 nd 0.024 ± 0.003
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untreated enzyme suggesting some effect on the distribution or number of enzyme 
intermediate complexes at steady state. This is likely due in part to the build-up of 
hydrogen peroxide and its previously described reversible inhibitory effect. The x-
intercept of the line generated from the turnover treated data is shifted significantly to 
the right of the intercept of the line generated from the untreated enzyme. This 
suggests that enzyme has been irreversibly inactivated during the two hours of 
turnover prior to assay. 
 
 
Figure 22: Plot of total enzyme concentration versus saturated initial enzyme 
velocity. Data points in blue represent those points treated with two hours in oxalate 
prior to assay. Points in black represent samples treated with two hours of incubation 
without oxalate prior to assay. Coefficients of determination for the linear fits are as 
follows: 0.989 for the 0 mM hydrogen peroxide plot, and 0.949 for the 10 mM 
hydrogen peroxide plot.  
 
Taken together, these data suggest that hydrogen peroxide is having two separate 
effects on the CsOxOx enzyme. That hydrogen peroxide behaves as a reversible 
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noncompetitive inhibitor as described in Chapter 3.1, but also the generation of 
hydrogen peroxide is linked to the turnover dependent irreversible inactivation of 
CsOxOx. 
The mechanism of hydrogen peroxide, turnover dependent inactivation of CsOxOx is 
not entirely clear. An alternative mechanism proposed in the literature suggests that 
the fraction of the enzyme containing Mn(III) represents the catalytically active 
enzyme form contrary to other proposed mechanisms6,14,20,55. In this alternative 
proposal, oxalate binds to the metal center followed by the subsequent 
decarboxylation of oxalate without the binding of diatomic oxygen to the metal 
center. The generated carbon dioxide anion radical then reacts with diatomic oxygen 
(possibly in bulk solution) to form carbon dioxide and a hydroperoxyl radical, a 
reaction for which there is chemical precedence56. EPR studies observing the 
persistence of free hydroperoxyl species are consistent with this proposal57. This 
proposal also suggests that the hydroperoxyl free radical is responsible for the 
reoxidation of Mn(II) to Mn(III), restarting the catalytic cycle. Loss of hydroperoxyl 
radical could thus prevent reoxidation of the metal center rendering it inactive. A 
similar mechanism of inactivation was proposed in an attempt to understand the 
observation of a spin trapped free-radical by EPR57. This mechanism proposes a 
“leaky” active site from which the intermediate carbon species can enter “bulk” 
solution. It was postulated in the literature that loss of the electron sink at the metal 
center could also result in the inactivation of the enzyme54. 
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Chapter 3.6: CsOxOx is not inactivated after anaerobic incubation in oxalate 
Discrepancies exist in our observations on CsOxOx and observations on barley 
oxalate oxidase from literature21. One example of this is the observation that barley 
oxalate oxidase is inactivated by catalase, while it has been shown here that catalase 
protects CsOxOx from inactivation. Additionally, Whitaker et al. observed 
irreversible inactivation of barley oxidase after anaerobic incubation in oxalate. 
Figure 23 shows the MIMS trace of the anaerobic incubation of CsOxOx in oxalate 
and the subsequent reintroduction of oxygen to the sample.  
 
Figure 23: Reaction trace highlighting the subsequent production of labelled carbon 
dioxide following oxygenation of buffered, nitrogen purged solution containing 
oxalate and CsOxOx. Signals for O2 and CO2 are shown here in orange and blue 
respectively. 
 
After reintroduction of oxygen, an increase is observed in the m/z 32 measurement 
shown in Figure 23. The generation of 13C labelled carbon dioxide immediately 
followed upon oxygen reintroduction suggesting that, while inactive under anaerobic 
conditions, CsOxOx retains its activity. The mechanism of deactivation of barley 
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oxalate oxidase described previously follows directly from Whitaker’s proposed 
catalytic mechanism21. In it oxalate directly reacts with the active Mn(III) center 
resulting in the carbon dioxide anion species. Without oxygen the intermediate 
species is unable to generate the hydroperoxyl radical proposed to regenerate the 
active enzyme form and the enzyme is stuck in the inactive reduced form. However, 
the observations of CsOxOx are not consistent with this mechanism; CsOxOx remains 
active after treatment with oxalate under anaerobic conditions. This supports the role 
of Mn(II) as the resting enzyme center species whose job is the reductive activation of 
diatomic oxygen. Furthermore, our results suggest a completely different mechanism 
of inactivation. One that requires enzymatic turnover in the presence of hydrogen 
peroxide reminiscent of the inactivation of catalase by hydrogen peroxide58,59.  
 
Chapter 3.7: Observed kinetic isotope effect on the CsOxOx mediated reaction 
with oxalate 
The change in reaction rate due to an isotopic substitution is called a kinetic isotope 
effect (KIE). There can be a number of factors that cause this observed effect 
including changes in symmetry of the reactant or its transition states due to isotope 
substitution, changes in moments of inertia, and/or changes in quantum tunneling. 
However, typically the most common explanation of the KIE is due to the change in 
the zero point energy of the vibrational energy bond under observation. This effect 
derives from the fact that the vibrational energy of two bonded species is dependent 
on the square root of the inverse of the reduced mass of the two bound species60. KIEs 
from hydrogen to deuterium or tritium exchange tend to be large due to the dramatic 
percent change in the reduced mass of the system. Quantum tunneling effects are 
more commonly observed in KIEs from hydrogen to deuterium or tritium 21,45. Larger 
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isotopically labelled molecules have a much smaller KIE and quantum tunneling 
becomes far less likely and the relative change in reduced mass after isotopic 
substitution is small. For this reason, only highly sensitive techniques can precisely 
measure heavier molecule KIEs. To demonstrate the sensitivity of the MIMS as well 
as gain further mechanistic insight, a KIE was observed for the CsOxOx mediated 
oxidative decarboxylation of oxalate using an intermolecular competition experiment. 
Figure 24 shows an example of a continuous reaction trace of the intermolecular 
competition experiment measured using MIMS. The black trace follows the oxidation 
of 12C oxalate over time via the measurement of 12C carbon dioxide change at m/z 44. 
The blue trace follows the oxidation of 13C oxalate over time by the measurement of 
13C carbon dioxide change at m/z 45. The V/V kinetic isotope effect of 1.05 was 
observed between the 13C labelled and unlabeled oxalate substrates, and is a normal 
estimate for the doubly labelled 13C kinetic isotope effect. This suggests that the 
carbon-carbon bond breaking step during catalysis is at least partially rate limiting. 
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Figure 24: MIMS reaction trace of an example intermolecular competition 
experiment in the estimation of the V/V kinetic isotope effect. The trace in black 
represents the increase in carbon dioxide from the 12C oxalate and the trace in blue 
represents the increase in carbon dioxide from the doubly labelled 13C oxalate.  
 
Chapter 3.8: Non-stoichiometric consumption of oxygen and production of 
carbon dioxide 
Studies reporting measurements of the stoichiometry of the oxalate oxidase catalyzed 
oxidative decarboxylation of oxalate are non-existent to the best of our knowledge. 
Figure 25 represents the first effort to study the observed stoichiometry of the oxalate 
oxidase mediated reaction as it relates to substrate concentration. Throughout the 
range of oxalate concentrations tested, the ratio of the production of carbon dioxide to 
the consumption of diatomic oxygen remains consistently at approximately 1.3 carbon 
dioxide molecules produced per diatomic oxygen consumed. This value is less than 
the theoretical value of 2 carbon dioxide molecules per oxygen molecule consumed. 
The consumption of additional oxygen per carbon dioxide molecule consumed 
suggests an alternative fate of an oxygen derived species. The generation of a 
hydroperoxyl radical is postulated in both proposed oxalate oxidase mechanisms and 
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has been observed in spin-trapping experiments on OxDC suggesting hydroperoxyl 
radicals are available in bulk solution57. Hydroperoxyl radicals are highly reactive and 
can cause oxidative damage to proteins and other biological macromolecules. In one 
proposed mechanism (Figure 3) the hydroperoxyl radical couples to the carbon 
dioxide radical anion forming hydrogen peroxide and carbon dioxide. In the event that 
the hydroperoxyl radical species reacts with a species other than the carbon dioxide 
anion, the carbon dioxide anion would be free to react with another molecule of 
diatomic oxygen resulting in the formation of an additional hydroperoxyl radical and, 
possibly, further oxidative damage. In an alternatively proposed mechanism21, the 
hydroperoxyl radical is generated from the reaction of carbon dioxide radical with 
diatomic oxygen. A pathway that accounts for the additional consumption of oxygen 
is not immediately apparent from this second proposal. 
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Figure 25: Plot of oxalate concentration versus the ration of carbon dioxide 
production to oxygen consumption. 
 
Chapter 3.9: CsOxOx catalyzes the oxidative decarboxylation of mesoxalate 
A proposal exists in the literature that OxOx non-oxidatively decarboxylates 
mesoxalate to yield glyoxylate and CO2
23. Figure 26 shows the reaction trace of the 
CsOxOx mediated mesoxalate reaction. The blue line follows the progression of the 
reaction by MIMS measuring the production of carbon dioxide at m/z 44. The orange 
line follows the consumption of diatomic oxygen throughout the OxOx mediated 
reaction. The black arrow indicates the time point at which CsOxOx was added to the 
reaction mixture. Subsequent to enzyme addition, carbon dioxide concentration 
increased and oxygen concentration decreased over time which is consistent with the 
production of carbon dioxide and the consumption of oxygen. 
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Figure 26: Reaction trace of the CsOxOx catalyzed mesoxalate reaction. The orange 
trace follows the consumption of diatomic oxygen at m/z 32. The blue trace follows 
the production of carbon dioxide at m/z 44. The black arrow signifies the addition of 
CsOxOx enzyme.  
 
Figure 27 shows the time course of the CsOxOx mediated mesoxalate reaction as a 
series of stacked HPLC chromatograms. Chromatograms at time points 0 minutes, 20 
minutes, 1 hour, 2 hours, and 24 hours contain peaks eluting at 6.8 minutes and 12.3 
minutes representing mesoxalate and succinate chemical species, respectively. 
Glyoxylate standards informed an expected retention time of 9.4 minutes. No peak 
eluting at 9.4 minutes was observed in any of the chromatograms. 
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Figure 27: HPLC stacked chromatograms following the CsOxOx mediated 
mesoxalate reaction over a period of 24 hours. 
 
Reaction rates were observable using the horseradish peroxidase coupled assay. 
Average rates are consistent with the rates observed using the MIMS assay. The 
observation of a rate using the coupled assay is dependent on the production of 
hydrogen peroxide by the reaction. 
The production of carbon dioxide, and hydrogen peroxide, and the consumption of 
oxygen by the CsOxOx mediated mesoxalate reaction are consistent with oxidative 
decarboxylation contrary to suggestions from literature suggesting that CsOxOx 
catalyzes the nonoxidative decarboxylation of mesoxalate to glyoxylate and carbon 
dioxide23. 
0 Hour 
1 Hour 
2 Hours 
24 Hours 
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CHAPTER 4: CONCLUSIONS 
Observations from MIMS kinetic experiments found that hydrogen peroxide is a 
reversible noncompetitive inhibitor of the CsOxOx mediated oxidative 
decarboxylation of oxalate. Additionally, HPLC and further MIMS experimentation 
found that CsOxOx undergoes a turnover dependent irreversible inactivation, and that 
catalase protects the enzyme from the described inactivation. CD spectra suggest 
hydrogen peroxide does not cause global structural change to CsOxOx in 
concentrations up to 20 mM. Additionally, anaerobic incubation of CsOxOx in 
oxalate does not inactivate the enzyme as was observed in barley oxalate oxidase. 
Studies observing the stoichiometry of the CsOxOx catalyzed oxidative 
decarboxylation of oxalate found that only 1.3 moles of carbon dioxide are produced 
per mole of oxygen consumed, and this observation differs from the theoretical 
stoichiometry in literature. An observed V/V kinetic isotope effect greater than 1 was 
observed for the CsOxOx mediated oxalate reaction suggesting that the carbon-carbon 
bond breaking step during catalysis is rate limiting. Finally, the CsOxOx mediated 
mesoxalate reaction consumes oxygen and produces hydrogen peroxide and carbon 
dioxide consistent with CsOxOx catalyzing the oxidative decarboxylation of 
mesoxalate. 
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APPENDIX A: CALIBRATION OF MIMS 
Calibration curves for each measured gas were generated. For carbon dioxide 
calibration, a stock solution of sodium carbonate/potassium bicarbonate (1 mM, pH 
10.2) is added into an acetic acid solution (50 mM) to produce a proportional 
concentration of CO2 in situ, and this entire process is monitored on the MIMS at m/z 
44. This experiment is repeated through a range of final CO2 concentrations, and the 
instrument response at m/z 44 at the height of the sample response peak is recorded at 
each concentration of CO2. The instrument response is then subtracted from the 
baseline, and the difference is then plotted against the associated concentration of 
CO2. 
Figure A1 shows an example calibration curve relating ion current response at m/z 44 
to carbonate generated carbon dioxide. In order to test the reproducibility, the slopes 
of the lines of fit of seven standard curves generated from carbonate (Method 2 
above), calibration plots were 2.49e-6, 2.31e-6, 2.11e-6, 1.7e-6, 2.23e-6, 2.22e-6, and 
2.42e-6 torr/mM. Respective intercepts were 1.20e-9, 4.68e-9, 3.27e-9, 7.18e-9, 
2.07e-9, 1.86e-9, and 2.32e-9 torr. Intercepts are all very much smaller than the slope 
of the calibration curve and their effects on the predicted number were assumed to be 
insignificant. Therefore, the slope of the calibration curve only was used to relate ion 
current to carbon dioxide concentration. Standard curves depend on a number of 
experimental variables including barometric pressure, temperature, stir rate and must 
be measured daily. 
Figure A2 shows an example calibration curve relating ion current response at m/z 32 
to dissolved oxygen made from mixtures of saturated oxygen and nitrogen solutions.  
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Figure A1: Example calibration curve relating carbonate generated carbon dioxide to 
ion current. 
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Figure A2: Example calibration curve relating dissolved oxygen concentration to ion 
current. 
 
A nitric oxide standard curve was generated via two reactions. The first reaction used 
was the decomposition of MAHMA nonoate at pH 4.0. Aliquots of a known 
concentration of MAHMA nonoate were added to a solution of succinate buffer at pH 
4.0 to achieve a range of nanomolar concentration of nitric oxide. The second method 
utilized the reaction in which nitrite is oxidized to nitric oxide by potassium iodide 
under acidic conditions. Aliquots of a known concentration of sodium nitrite solution 
were added to a solution of 0.1M sulfuric acid to achieve a range of nanomolar 
concentration of nitric oxide detectable on the MIMS at m/z 30. 
Figure A3 shows an example calibration curve relating nonoate derived nitric oxide 
concentration and ion current at 30 m/z. The average slope of the best fit line to the 
calibration curve was 1.33 x 10-12 nM-1 ± 0.32 x 10-12 nM-1. The intercepts were small 
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compared to the ion current reading at 0 nM nitric oxide. The nonoate standard curves 
varied in shape from linear to hyperbolic. The diminishing returns in signal for higher 
nitric oxide concentrations is likely due to the combination of nitric oxide reacting 
with oxygen and water to form nitrite as well as the escape of nitric oxide from the 
solution. 
 
Figure A3: Example MIMS calibration curve relating MAHMA nonoate derived 
nitric oxide to ion current. 
 
Figure A4 shows an example calibration curve relating nitrite derived nitric oxide 
concentration and ion current at 30 m/z. The average slope of the best fit line to the 
calibration curve was 1.68 x 10-12 nM-1 ± 0.06 x 10-12 nM-1. Intercepts were small 
compared to the 0 nM nitric oxide blank. The nitrite derived nitric oxide calibration 
curves are far more reproducible than those generated from nonoate. Under the 
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conditions of the measurement the nitrite produced by nitric oxides reaction with 
oxygen and water is converted back to nitric oxide by potassium iodide.  
 
Figure A4: Example MIMS calibration curve relating nitrite derived nitric oxide to 
ion current. 
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APPENDIX B: DETECTION OF NITRIC OXIDE BY MIMS PROVIDES A BASIS 
FOR A NITRIC OXIDE SYNTHASE ASSAY 
 
Nitric oxide synthases (NOS, EC 1.14.13.39) catalyze the oxygen and NADPH-
dependent oxidation of L-arginine to citrulline and NO61. These enzymes possess 
different biochemical and regulatory attributes depending on the tissue from which 
they are derived. Understanding these enzymes is essential to understanding cellular 
signaling, vasodilation, and oxidative stress. Despite much effort and numerous 
available methods, detection of NO in biological samples remains a difficult task with 
each method possessing limitations and complex considerations. Methods available to 
assess NOS synthase activity include the Griess reaction62 and the measurement of the 
conversion of oxyhemoglobin to methemoglobin63. Membrane inlet mass 
spectrometry (MIMS) has been applied to the detection and measurement of NO64. 
Here we further the application of MIMS to the detection of NO by using a 
commercially available instrument and probe assembly and by applying this method 
to the assay of NOS. 
Nitric oxide synthase (inducible from mouse, iNOS) and MAHMA nonoate were 
purchased from Sigma Aldrich. Other reagents were of the highest purity available 
and were purchased from either Sigma Aldrich or Fisher Scientific. Figures A2 and 
A3 in Appendix A show the calibration of the MIMS ion current to the concentration 
of NO generated from MAHMA nonoate and sodium nitrite, respectively. As may be 
seen from the calibration curves, the detection of NO by MIMS is linear over a range 
from 60 to 2000 nM. The lower level of detection of the spectrophotometric Griess 
reagent system is 1.0 µM. 
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Figure B1: End point assay measuring the production of nitric oxide at m/z 30 of the 
nitric oxide synthase mediated reaction. 
 
We demonstrate the utility of MIMS in the assay of NOS by an end point assay 
(Figure B1) and a direct, continuous assay (Figure B2). Reaction mixtures contained 1 
mM arginine, 1 mM magnesium acetate, 0.15 mM NADPH, 180 µM DTT, 18 µM 
THB, and 50 mM HEPES, pH 7.4. For the end point assay, samples were quenched at 
20, 30, 40, and 50 minutes by addition of an aliquot of the reaction mixture into the 
0.1 M H2SO4/0.1 M KI solution and the m/z 30 was measured. For the direct, 
continuous method, the MIMS probe was placed directly into a cuvette containing the 
stirred reaction mixture (maintained at 37oC) and the reaction was initiated by the 
addition of enzyme. Results from these two assays methods yield comparable results 
(0.038 U/mg for the end point assay and 0.024 U/mg for the continuous assay). These 
experiments provide a basis for the application of MIMS for the assay of NOS.  
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Figure B2: Reaction trace measuring the production of nitric oxide at m/z 30 of the 
nitric oxide synthase mediated reaction. The black arrow indicates the addition of 
nitric oxide synthase enzyme.  
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APPENDIX C: TARTRONIC ACID AND DIETHYL KETOMALONATE AS 
ALTERNATIVE SUBSTRATES 
As introduced in Chapter 1.8, understanding the degree of promiscuity (substrate 
ambiguity) of CsOxOx is important to provide insights into the molecular features 
that allow some enzymes to utilize a broad range of substrates, the role substrate 
ambiguity may play in enzyme evolution, and to guide efforts to tailor enzymes as 
biocatalysts.  In the HRP coupled assay, tartronic acid and diethyl ketomalonate 
appear as weak inhibitors, each with KI values of approximately 10 mM (data not 
shown). Assessing whether or not these three-carbon molecules that share structural 
similarities with mesoxalate, serve as substrates was not possible using the HRP 
coupled assay. We, therefore, employed the MIMS assay (as described in Chapter 2.7) 
to determine whether or not they serve as alternative substrates and to acquire initial 
rate data under saturating conditions.  
Representative traces are shown in Figure C1 (tartronic acid) and Figure C2 (diethyl 
ketomalonate). The results are summarized as activities relative to oxalate in Table 
B1. That tartronic acid only possesses 4% of the activity relative to oxalate and 
approximately 10% relative to mesoxalate emphasizes the importance of the alpha 
carbonyl oxygen in mesoxalate in contrast to the hydroxyl group in that position in 
tartronic acid. That diethyl ketomalonate (diethyl mesoxalate) serves as a substrate 
with a significant rate (12% relative to oxalate and 28% relative to mesoxalate) raises 
interesting questions about how this molecule fits into the active site and binds to the 
metal center. Proton NMR studies were carried out (data not shown) that demonstrate 
that the aqueous samples tested for activity had not been hydrolyzed to the carboxylic 
acid. These data showing that tartronic acid and diethyl ketomalonate serve as 
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alternative substrates expand our understanding of the degree of substrate promiscuity 
of the CsOxOx catalyzed reaction51 and may motivate future work to identify the 
amino acid residues involved in this promiscuity that may, in turn, provide insight 
into the evolutionary path that CsOxOx has taken and delineate a path toward its 
modification for its use as a biocatalyst.  
 
 
Figure C1: Reaction trace measuring the production of carbon dioxide at m/z 44 of 
the CsOxOx mediated reaction using tartronic acid as a substrate. The black arrow 
indicates the addition of CsOxOx enzyme.  
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Figure C2: Reaction trace measuring the production of carbon dioxide at m/z 44 of 
the CsOxOx mediated reaction using diethyl ketomalonate as a substrate. The black 
arrow indicates the addition of CsOxOx enzyme.  
 
Table C1: Relative activities of the CsOxOx catalyzed reaction utilizing mesoxalate, 
tartronic acid, and diethyl ketomalonate. Activities are relative to that with oxalate in 
50 mM sodium succinate, pH 4.0. 
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APPENDIX D: OXIDATION OF 13C GLYOXYLATE TO 13C MESOXALATE 
In order to improve the sensitivity of  the MIMS assay of the CsOxOx catalyzed 
mesoxalate reaction, an effort was made to synthesize 13C3-mesoxalate. Triply 
labelled 13C mesoxalate is unavailable commercially and, therefore, we attempted to 
synthesize it from 13C3-glycerol prior to kinetic studies. A literature method 
demonstrated a one-pot, high yield, mesoxalate synthesis procedure starting from 
glycerol, utilizing TEMPO as a catalyst, and bleach as the distal oxidant52,65. 
Mesoxalate synthesis was carried out on triply label 13C glycerol according to the 
literature procedure. The identity and purity of 13C mesoxalate was determined using 
HPLC and 13C NMR. Two sample solutions of synthesis product were dissolved in 
mobile phase (2.2 g/L). One sample was spiked with a concentrated solution of 
sodium mesoxalate monohydrate (Sigma-Aldrich) (0.1 mM) prior to both samples 
being filtered through 0.45 micron syringe filter and extensively degassed under 
vacuum. The HPLC chromatogram of synthesized product showed a strong peak at 
6.7 minutes that agrees with the spiked sample chromatogram peak at 6.9 minutes and 
is consistent with a mesoxalate product (Figure D1). However, it should be noted that 
mesoxalate co-elutes with oxalate. 
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Figure D1: HPLC chromatogram of the standard spiked and unspiked mesoxalate 
synthesis product. 
 
13C NMR spectra were used to confirm the identity of the reaction products. Figure 
D2 shows the NMR spectrum of the synthesis product(s). The doublet at 174.8 ppm is 
consistent with a highly deshielded carboxylate 13C nucleus adjacent to another 
carbon nucleus, and is also consistent with a mesoxalate product. The triplet at 73.4 
ppm is consistent with a moderately shielded 13C nucleus adjacent to two different 13C 
nuclei; peak of the correct multiplicity but shifted further up field than what would be 
expected for a mesoxalate product. The strong singlet at 170.7 ppm is consistent with 
a one unique 13C nucleus or a group of identical 13C nuclei and is not consistent with a 
mesoxalate product. Figure D3 shows the 13C NMR spectrum of a store-bought 13C 
saturated sodium oxalate sample at pH 4.0. This spectrum shows a strong singlet at 
169 ppm. Furthermore, the singlet peaks overlap in a 13C NMR of the synthesis 
product spiked with store-bought 13C oxalate (Figure D4), consistent with an oxalate 
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synthesis product. Thus, TEMPO and sodium hypochlorite oxidize glycerol to oxalate 
as the major product. 
 
Figure D2: 13C NMR of the TEMPO mediated glycerol reaction product at pH 4.0. 
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Figure D3: 13C NMR of saturated C13 sodium oxalate at pH 4.0. 
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Figure D4: 13C NMR of the TEMPO mediated glycerol reaction product spiked with 
13C sodium oxalate at pH 4.0. 
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